Jolley Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Jolley Asset Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,600	Closed	-$69K	–	184
2017 Q2	$69K	Hold	1,600	–	–	0.05%	94
2017 Q1	$67K	Hold	1,600	–	–	0.05%	90
2016 Q4	$63K	Hold	1,600	–	–	0.05%	94
2016 Q3	$71K	Hold	1,600	–	–	0.06%	86
2016 Q2	$67K	Hold	1,600	–	–	0.05%	93
2016 Q1	$64K	Hold	1,600	–	–	0.06%	80
2015 Q4	$82K	Hold	1,600	–	–	0.08%	59
2015 Q3	$75K	Hold	1,600	–	–	0.08%	59
2015 Q2	$100K	Hold	1,600	–	–	0.09%	60
2015 Q1	$99K	Hold	1,600	–	–	0.08%	61
2014 Q4	$86K	Hold	1,600	–	–	0.07%	64
2014 Q3	$85K	Hold	1,600	–	–	0.07%	63
2014 Q2	$83K	Hold	1,600	–	–	0.06%	70
2014 Q1	$75K	Hold	1,600	–	–	0.06%	66
2013 Q4	$70K	Hold	1,600	–	–	0.06%	64
2013 Q3	$62K	Hold	1,600	–	–	0.05%	70
2013 Q2	$56K	Buy	+1,600	New	+$54K	0.05%	70

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jolley Asset Management's XPH Position: Q3 2017 in Review

Jolley Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2017, closing a stake of 1,600 shares — an estimated $69K sold.

Jolley Asset Management first reported a position in XPH in Q2 2013 and held it in 17 quarters. The position peaked at $100K in Q2 2015. 79 funds tracked by Wall St. Rank hold XPH as of Q3 2017.

Jolley Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
Jolley Asset Management sold 1,600 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2017, an estimated $69K.
Jolley Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 17 quarters.
Jolley Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $100K in Q2 2015.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2017.

Based on Jolley Asset Management's 13F filing for Q3 2017, filed 12 Oct 2017.